Bridgeway Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $356K | Hold |
|
|||||
|
2025
Q2 | $225K | Buy |
|
|||||
|
2025
Q1 | $109K | Sell |
|
|||||
|
2024
Q4 | $266K | Sell |
|
|||||
|
2024
Q3 | $497K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.27M | Buy |
|
|||||
|
2018
Q2 | $2.76M | Buy |
|
|||||
|
2018
Q1 | $1.88M | Sell |
|
|||||
|
2017
Q4 | $1.38M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $720K | Hold |
|
|||||
|
2017
Q1 | $616K | Hold |
|
|||||
|
2016
Q4 | $670K | Hold |
|
|||||
|
2016
Q3 | $532K | Hold |
|
|||||
|
2016
Q2 | $441K | Hold |
|
|||||
|
2016
Q1 | $587K | Hold |
|
|||||
|
2015
Q4 | $660K | Buy |
|